STEMCELL Technologies Signs Exclusive License with Propagenix to Commercialize EpiX™, an Innovation Empowering Epithelial Cell Biology and Cell Therapy

STEMCELL Technologies has signed an exclusive license with Propagenix of Rockville, MD to commercialize its patented EpiX™ technology, a novel and revolutionary cell culture medium that enables unprecedented expansion of tissue-resident epithelial stem cells without any genetic manipulation